Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2001 Nov;85(5):386–390. doi: 10.1136/adc.85.5.386

Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery

R Booy 1, P Habibi 1, S Nadel 1, C de Munter 1, J Britto 1, A Morrison 1, M Levin 1, t M Group 1
PMCID: PMC1718959  PMID: 11668100

Abstract

BACKGROUND AND AIMS—The case fatality rate from meningococcal disease (MD) has remained relatively unchanged in the post antibiotic era, with 20-50% of patients who develop shock still dying. In 1992 a new paediatric intensive care unit (PICU) specialising in MD was opened. Educational information was disseminated to local hospitals, and a specialist transport service was established which delivered mobile intensive care. The influence of these changes on mortality of children with MD was investigated.
METHODS—A total of 331 consecutive children with meningococcal disease admitted to the PICU between 1992 and 1997 were studied. Severity of the disease on admission was assessed using the paediatric risk of mortality (PRISM) score. Logistic regression analysis was used to correct for clinical severity, age, and sex; death was the outcome, and year of admission, a temporal trend variable, was the primary exposure.
RESULTS—The case fatality rate fell year on year (from 23% in 1992/93 to 2% in 1997) despite disease severity remaining largely unchanged. After adjustment for age, sex, and disease severity, the overall estimate for improvement in the odds of death was 59% per year (odds ratio for the yearly trend 0.41).
CONCLUSIONS—A significant improvement in outcome for children admitted with MD to a PICU has occurred in association with improvements in initial management of patients with MD at referring hospitals, use of a mobile intensive care service, and centralisation of care in a specialist unit.



Full Text

The Full Text of this article is available as a PDF (156.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Algren J. T., Lal S., Cutliff S. A., Richman B. J. Predictors of outcome in acute meningococcal infection in children. Crit Care Med. 1993 Mar;21(3):447–452. doi: 10.1097/00003246-199303000-00024. [DOI] [PubMed] [Google Scholar]
  2. Best C., Walsh J., Sinclair J., Beattie J. Early haemo-diafiltration in meningococcal septicaemia. Lancet. 1996 Jan 20;347(8995):202–202. doi: 10.1016/s0140-6736(96)90389-x. [DOI] [PubMed] [Google Scholar]
  3. Britto J., Nadel S., Maconochie I., Levin M., Habibi P. Morbidity and severity of illness during interhospital transfer: impact of a specialised paediatric retrieval team. BMJ. 1995 Sep 30;311(7009):836–839. doi: 10.1136/bmj.311.7009.836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. De Munter C., Nadel S., Britto J., Habibi P., Levin M. ECMO for refractory cardiorespiratory failure due to meningococcal disease. Lancet. 1997 May 10;349(9062):1398–1398. doi: 10.1016/S0140-6736(05)63240-0. [DOI] [PubMed] [Google Scholar]
  5. Derkx B., Wittes J., McCloskey R. Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group. Clin Infect Dis. 1999 Apr;28(4):770–777. doi: 10.1086/515184. [DOI] [PubMed] [Google Scholar]
  6. Derkx H. H., van den Hoek J., Redekop W. K., Bijlmer R. P., van Deventer S. J., Bossuyt P. M. Meningococcal disease: a comparison of eight severity scores in 125 children. Intensive Care Med. 1996 Dec;22(12):1433–1441. doi: 10.1007/BF01709565. [DOI] [PubMed] [Google Scholar]
  7. Giroir B. P., Quint P. A., Barton P., Kirsch E. A., Kitchen L., Goldstein B., Nelson B. J., Wedel N. J., Carroll S. F., Scannon P. J. Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis. Lancet. 1997 Nov 15;350(9089):1439–1443. doi: 10.1016/s0140-6736(97)06468-4. [DOI] [PubMed] [Google Scholar]
  8. Goldman A. P., Kerr S. J., Butt W., Marsh M. J., Murdoch I. A., Paul T., Firmin R. K., Tasker R. C., Macrae D. J. Extracorporeal support for intractable cardiorespiratory failure due to meningococcal disease. Lancet. 1997 Feb 15;349(9050):466–469. doi: 10.1016/s0140-6736(96)12106-1. [DOI] [PubMed] [Google Scholar]
  9. Havens P. L., Garland J. S., Brook M. M., Dewitz B. A., Stremski E. S., Troshynski T. J. Trends in mortality in children hospitalized with meningococcal infections, 1957 to 1987. Pediatr Infect Dis J. 1989 Jan;8(1):8–11. doi: 10.1097/00006454-198901000-00003. [DOI] [PubMed] [Google Scholar]
  10. Kirsch E. A., Barton R. P., Kitchen L., Giroir B. P. Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience. Pediatr Infect Dis J. 1996 Nov;15(11):967–979. doi: 10.1097/00006454-199611000-00009. [DOI] [PubMed] [Google Scholar]
  11. Levin M., Quint P. A., Goldstein B., Barton P., Bradley J. S., Shemie S. D., Yeh T., Kim S. S., Cafaro D. P., Scannon P. J. Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group. Lancet. 2000 Sep 16;356(9234):961–967. doi: 10.1016/s0140-6736(00)02712-4. [DOI] [PubMed] [Google Scholar]
  12. Pathan N., Nadel S., Levin M. Pathophysiology and management of meningococcal septicaemia. J R Coll Physicians Lond. 2000 Sep-Oct;34(5):436–444. [PMC free article] [PubMed] [Google Scholar]
  13. Paulson T. E., Spear R. M., Silva P. D., Peterson B. M. High-frequency pressure-control ventilation with high positive end-expiratory pressure in children with acute respiratory distress syndrome. J Pediatr. 1996 Oct;129(4):566–573. doi: 10.1016/s0022-3476(96)70122-1. [DOI] [PubMed] [Google Scholar]
  14. Poland G. A. Still more questions on pertussis vaccines. Lancet. 1997 Nov 29;350(9091):1564–1565. doi: 10.1016/S0140-6736(97)22048-9. [DOI] [PubMed] [Google Scholar]
  15. Pollack M. M. Pediatric transport research: it is improving (finally) Crit Care Med. 1994 Jul;22(7):1073–1074. doi: 10.1097/00003246-199407000-00003. [DOI] [PubMed] [Google Scholar]
  16. Pollack M. M., Ruttimann U. E., Getson P. R. Pediatric risk of mortality (PRISM) score. Crit Care Med. 1988 Nov;16(11):1110–1116. doi: 10.1097/00003246-198811000-00006. [DOI] [PubMed] [Google Scholar]
  17. Pollard A. J., Britto J., Nadel S., DeMunter C., Habibi P., Levin M. Emergency management of meningococcal disease. Arch Dis Child. 1999 Mar;80(3):290–296. doi: 10.1136/adc.80.3.290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Smith O. P., White B., Vaughan D., Rafferty M., Claffey L., Lyons B., Casey W. Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans. Lancet. 1997 Nov 29;350(9091):1590–1593. doi: 10.1016/s0140-6736(97)06356-3. [DOI] [PubMed] [Google Scholar]
  19. Tilford J. M., Roberson P. K., Lensing S., Fiser D. H. Differences in pediatric ICU mortality risk over time. Crit Care Med. 1998 Oct;26(10):1737–1743. doi: 10.1097/00003246-199810000-00032. [DOI] [PubMed] [Google Scholar]
  20. Tryba M. Stress ulcer prophylaxis and gastric alkalinization--death of a myth? Intensive Care Med. 1992;18(1):1–3. doi: 10.1007/BF01706416. [DOI] [PubMed] [Google Scholar]
  21. Zenz W., Muntean W., Gallistl S., Zobel G., Grubbauer H. M. Recombinant tissue plasminogen activator treatment in two infants with fulminant meningococcemia. Pediatrics. 1995 Jul;96(1 Pt 1):144–148. [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES